glp 1 agonist gastric emptying GLP-1 Agonists For Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Gastrointestinal (GI) Side Effects of

Sublingual drops reach peak levels within 1-3 hours of administration but clear the system faster, which is why they are typically dosed daily

n , AUC of m

15 GLP-1RAs also improve -cell proliferation and inhibit -cell apoptosis to promote cellular survival by preventing oxidative stress and lipotoxicity

Clinical studies have demonstrated that GLP-1 receptor agonists can reduce various inflammatory biomarkers , including: C-reactive protein (CRP) : A general marker of systemic inflammation Interleukin-6 (IL-6) : A pro-inflammatory cytokine Tumour necrosis factor-alpha (TNF-) : Another key inflammatory mediator Plasminogen activator inhibitor-1 (PAI-1) : Associated with cardiovascular inflammation The magnitude of these effects varies between studies and may depend on baseline inflammatory status, degree of weight loss achieved, and individual patient characteristics

Reducing processed foods, sugar, and unhealthy fats is also crucial

Elkind-Hirsch et al